Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study

Authors: Matthew J. Koster, Cynthia S. Crowson, Rachel Giblon, Jane Jaquith, Alí Duarte‐García, Eric L. Matteson, Cornelia M. Weyand, Kenneth J. Warrington - Annals of the Rheumatic Diseases 2022 cited by 85